Key result
Patients with non-valvular atrial fibrillation and cardiac thrombosis had lower left ventricular ejection fraction and peak left atrial appendage emptying velocity compared to those without thrombosis.
Why the study?
Structural cardiac remodeling in non-valvular atrial fibrillation causes thromboembolic complications despite oral anticoagulation, warranting comparative analysis of patients with and without atrial thrombotic masses.
Observational (n=50)
No
Answers are grounded in this paper and cite their sources.
In patients with NVAF on optimal anticoagulation, left atrial thrombi remain present in 14% and are associated with higher CHA2DS2-VASc scores, reduced LVEF, and lower LAA emptying velocity.
Objectives - Structural cardiac, mainly atrial remodeling in non-valvular atrial fibrillation (NVAF) creates conditions for thromboembolic complications, despite the optimization of oral anticoagulant treatment over the past years. This study aims to provide a comparative analysis of patients with NVAF, with and without atrial thrombotic masses, in an integrated approach using clinical, electrocardiographic, anatomohemodynamic cardiac findings assessed by echocardiography, as well as an evaluation of the inflammatory status based on the usual screening blood markers. Methods – The study was based on the anonymous analysis of the medical records of 50 patients with NVAF monitored in a center of cardiology in Cluj-Napoca between March 2019 – February 2020, who received optimal oral anticoagulant treatment, all undergoing transesophageal ultrasound prior to cardioversion or ablation therapy. The statistical data processing methods were based on the “chi square” test and overall model fit logistic regression. Results – Atrial thrombotic complications were found in 7 (14%) patients with NVAF. These had, compared to patients without thrombotic masses, a mean CHA2DS2-VASc scale of 3 versus 2.76 (p=0.05), more frequently other atrial tachyarrhythmias (p<0.01), a more expressed inflammatory reaction (p=0.02), as well as a reduction of LVEF (p<0.01) and the peak left atrial appendage emptying velocity (p<0.01). Conclusions – In addition to a high CHA2DS2-VASc score, left anatomohemodynamic cardiac alteration, atrial arrhythmic complexity and background inflammatory status create conditions for high thromboembolic risk in patients with NVAF.
No takes yet. Share an insight, caveat, or question.
BLAGA et al. (2021) conducted an observational in Non-valvular atrial fibrillation (n=50). Cardiac thrombosis or spontaneous contrast vs. No cardiac thrombosis or spontaneous contrast was evaluated on Left ventricular ejection fraction (LVEF) (p=<0.01). Patients with non-valvular atrial fibrillation and cardiac thrombosis had lower left ventricular ejection fraction and peak left atrial appendage emptying velocity compared to those without thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: